Ritchey M L, Shamberger R C, Haase G, Horwitz J, Bergemann T, Breslow N E
Department of Surgery, University of Texas-Houston Medical School, USA.
J Am Coll Surg. 2001 Jan;192(1):63-8; quiz 146. doi: 10.1016/s1072-7515(00)00749-3.
Surgical complications are a recognized morbidity of the treatment of patients with Wilms tumor. This study examines the incidence of surgical complications in the most recently completed study from the National Wilms' Tumor Study Group (NWTSG).
The fourth National Wilms' Tumor Study (NWTS-4) enrolled 3,335 patients from August 1986 to August 1994. A random sample of 534 patients was selected from 2,290 eligible patients randomized to treatment regimens or enrolled in the followed category and treated according to NWXTSG protocol. The patient records received at the NWTSG Data and Statistical Center were analyzed for surgical complications (intraoperative and postoperative).
Sixty-eight patients (12.7%) experienced 76 complications. Intestinal obstruction was the most common complication (5.1% of patients), followed by extensive hemorrhage (1.9%), wound infection (1.9%), and vascular injury (1.5%). The incidence of surgical complications in NWTS-4 was significantly lower than NWTS-3 (12.7% versus 19.8%, p < 0.001). There has been a marked decrease in the risk of extensive intraoperative bleeding and major intraoperative complications. Factors previously shown to be associated with an increased risk for surgical complications, together with indicators of type of hospital and surgeon specialty, were analyzed by multiple logistic regression analysis. Intravascular extension into the inferior vena cava (IVC), the atrium, or both (p = 0.02; odds ratio [OR] 3.8, 95% confidence interval [CI] 1.2, 11.8), and nephrectomy performed through a flank or paramedian incision (p = 0.02; OR 5.3, 95% CI 1.3, 22) were both associated with increased risk of complications. Tumor diameter greater than or equal to 10cm was also associated with an increased risk of surgical complications (p = 0.05; OR 2.0, 95% CI 1.0, 3.9). The risk of complications was higher if the nephrectomy was performed by a general surgeon (OR 9.0, 95% CI 1.3, 65; p = 0.03) rather than a pediatric surgeon (reference group, OR 1.0) or pediatric urologist (OR 0.7, 95% CI 0.3, 1.8).
The incidence of surgical complications in NWTSG patients undergoing primary nephrectomy has significantly decreased over the past decade. But surgical morbidity should not be overlooked. It is important that surgeons treating young children with solid tumors are aware of their role and the potential risks encountered in removal of the primary tumor. This study found that surgical specialists who primarily treat children can perform these operations with lower surgical morbidity.
手术并发症是肾母细胞瘤患者治疗中公认的一种发病率。本研究调查了国家肾母细胞瘤研究组(NWTSG)最近完成的研究中手术并发症的发生率。
第四届国家肾母细胞瘤研究(NWTS - 4)于1986年8月至1994年8月招募了3335例患者。从2290例符合条件并随机分配至治疗方案组或纳入随访组且按照NWTSG方案治疗的患者中随机抽取了534例患者。对NWTSG数据与统计中心收到的患者记录进行手术并发症(术中及术后)分析。
68例患者(12.7%)发生了76例并发症。肠梗阻是最常见的并发症(占患者的5.1%),其次是广泛出血(1.9%)、伤口感染(1.9%)和血管损伤(1.5%)。NWTS - 4中手术并发症的发生率显著低于NWTS - 3(12.7%对19.8%,p < 0.001)。广泛术中出血和主要术中并发症的风险已显著降低。通过多因素logistic回归分析对先前显示与手术并发症风险增加相关的因素以及医院类型和外科医生专业指标进行了分析。肿瘤血管延伸至下腔静脉(IVC)、心房或两者(p = 0.02;比值比[OR] 3.8,95%置信区间[CI] 1.2,11.8),以及经侧腹或旁正中切口进行肾切除术(p = 0.02;OR 5.3,95% CI 1.3,22)均与并发症风险增加相关。肿瘤直径大于或等于10cm也与手术并发症风险增加相关(p = 0.05;OR 2.0,95% CI 1.0,3.9)。如果肾切除术由普通外科医生进行(OR 9.0,95% CI 1.3,65;p = 0.03),而不是小儿外科医生(参照组,OR 1.0)或小儿泌尿科医生(OR 0.7,95% CI 0.3,1.8),并发症风险更高。
在过去十年中,接受初次肾切除术的NWTSG患者手术并发症的发生率显著降低。但手术发病率不应被忽视。治疗实体瘤患儿的外科医生意识到自己的作用以及在切除原发肿瘤时可能遇到的潜在风险非常重要。本研究发现,主要治疗儿童的外科专科医生进行这些手术时手术发病率较低。